Skip to main navigation
Skip to search
Skip to main content
HSC Home
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Search by expertise, name or affiliation
Evolving relevance of neuroproteomics in Alzheimer’s disease
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Evolving relevance of neuroproteomics in Alzheimer’s disease'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Alzheimer's Disease
100%
Neuroproteomics
100%
Biological Systems
100%
Early Detection
66%
Systems Biology
66%
Early Diagnosis
66%
Mass Spectrometry
66%
Alzheimer's Disease Diagnosis
66%
Disease Mechanisms
33%
Microarray
33%
Proteomics
33%
Biological Markers
33%
Age-related Neurodegeneration
33%
Positive Predictive Value
33%
Negative Predictive Value
33%
Mechanism Development
33%
Prognostic Ability
33%
Computational Modeling
33%
Early Therapy
33%
Biomarker Discovery
33%
Biomarker Validation
33%
Biological Cells
33%
Biological Fluids
33%
Molecular Datasets
33%
Hypothesis-driven
33%
Technological Platform
33%
Scientific Frontiers
33%
Development Validation
33%
Biomarker Candidates
33%
Methodological Innovation
33%
Dynamic Features
33%
Clinical Prognosis
33%
Prospective Biomarkers
33%
High-throughput Technologies
33%
Diagnostic Functions
33%
Biological Organs
33%
Experimental Biology
33%
Therapy Development
33%
Fluid Cell
33%
Performance Profiling
33%
Protein-peptide Complexes
33%
Biochemistry, Genetics and Molecular Biology
Neuroproteomics
100%
Mass Spectrometry
100%
Liquid
50%
Microarrays
50%
Proteomics
50%
Biomarker Discovery
50%
Protein Characterization
50%
Biomarker Validation
50%